In January 1961, Dr. Tomisaku Kawasaki saw his first case of a 4-year-old boy with what is now known as Kawasaki disease. He described this boy as having a Bunique symptom complexĥ e had never seen before and had to discharge the boy with an unknown diagnosis [5] . Over the next 5 years, Dr. Kawasaki recognised additional similar cases, which he meticulously documented and published in 1967 under the lengthy name of BFebrile oculo-oro-cutaneo-acrodesquamatous syndrome with or without acute non-suppurative cervical lymphadenitis in infancy and childhood^ [3] . Today, Kawasaki disease together with rheumatic heart disease are the leading causes of acquired heart disease in children [6] . Despite this, clinical recognition of Kawasaki disease in children with a prolonged febrile illness remains challenging-particularly in those with incomplete Kawasaki disease where fewer than four of the principal clinical findings manifest. In this issue of the European Journal of Paediatrics, Dietz et al. present a concise update on the current diagnostic criteria for Kawasaki disease including for children presenting with incomplete Kawasaki disease [2] . This review may also be read in parallel with the most recent update of the scientific statement by the American Heart Association on diagnosis, treatment, and long-term management of Kawasaki disease [4] . While significant progress has been made in understanding the epidemiology and clinical aspects of Kawasaki disease over the last 50 years, many aspects regarding aetiology, immunology and host genetics remain unanswered. Dietz et al. seek to summarise recent advances in this state-of-the-art review [2] . Further, an increasing number of patients with Kawasaki disease now reach adulthood, and as a result, long-term prognosis has become an important discussion point for all specialists caring for these patients [1] . A succinct summary of data on long-term follow-up in patients with Kawasaki disease including their cardiovascular risk, issues surrounding quality-of-life, and its impact on social behaviour is provided and will be helpful for discussion with patients and families.
